SPDWvsXPH
SPDR Portfolio Developed World ex-US ETF against SPDR S&P Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| SPDW | XPH | |
|---|---|---|
| Expense ratio | 0.030% | 0.35% |
| Assets | $40.7B | $440M |
| Net flow, 1 month | +$609M | −$80M |
| Net flow, 1 year | +$4.8B | +$206M |
| Return, YTD | +11.8% | +14.2% |
| Return, 1 year | +12.8% | +30.2% |
| Avg daily volume | 3.1M | 198K |
| Holdings | 2480 | 41 |
| Listed | Apr 20, 2007 | Jun 19, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS